Denmark on Monday announced it will not use the Johnson & Johnson COVID-19 vaccine because the shot is potentially linked to blood clots. “The Danish Health Authority has concluded that the benefits of using the COVID-19 vaccine from Johnson & Johnson do not outweigh the risk of causing the possible adverse effect, VITT, in those who receive the vaccine,” the authority said in a statement. VITT refers to the severe cases of blood clots, a small number of which have led to deaths among those who got a shot. The decision to move forward without the Johnson & Johnson vaccine came after Danish officials reviewed international data and statements. Denmark previously dropped AstraZeneca’s jab because of its possible link to blood clots. “In the midst of an epidemic, this has been a difficult decision to make, especially since we have also had to discontinue using the COVID-19 vaccine from AstraZeneca. …